Roles of cAMP and cAMP-dependent protein kinase in the progression of prostate cancer: cross-talk with the androgen receptor.
about
Nuclear import of LASP-1 is regulated by phosphorylation and dynamic protein-protein interactionsCardiovascular Dysfunction Following Burn Injury: What We Have Learned from Rat and Mouse ModelsNeuroendocrine differentiation in prostate cancer: a mechanism of radioresistance and treatment failureMechanisms of apoptosis by the tumor suppressor Par-4β-Adrenergic Receptor Signaling in Prostate CancerHuman phosphodiesterase 4D7 (PDE4D7) expression is increased in TMPRSS2-ERG-positive primary prostate cancer and independently adds to a reduced risk of post-surgical disease progressionThe cAMP phosphodiesterase-4D7 (PDE4D7) is downregulated in androgen-independent prostate cancer cells and mediates proliferation by compartmentalising cAMP at the plasma membrane of VCaP prostate cancer cellsn-Butyl benzyl phthalate promotes breast cancer progression by inducing expression of lymphoid enhancer factor 1Neonatal exposure to estradiol/bisphenol A alters promoter methylation and expression of Nsbp1 and Hpcal1 genes and transcriptional programs of Dnmt3a/b and Mbd2/4 in the rat prostate gland throughout lifeThe role of PI3K/AKT-related PIP5K1α and the discovery of its selective inhibitor for treatment of advanced prostate cancer.Melanoma antigen-A11 (MAGE-A11) enhances transcriptional activity by linking androgen receptor dimers.Type 10 soluble adenylyl cyclase is overexpressed in prostate carcinoma and controls proliferation of prostate cancer cellsIonizing radiation induces neuroendocrine differentiation of prostate cancer cells in vitro, in vivo and in prostate cancer patientsPlasma genetic and genomic abnormalities predict treatment response and clinical outcome in advanced prostate cancerPhosphodiesterase sequence variants may predispose to prostate cancer.Influenza A virus induces interleukin-27 through cyclooxygenase-2 and protein kinase A signalingPost-translational Down-regulation of Melanoma Antigen-A11 (MAGE-A11) by Human p14-ARF Tumor Suppressor.The pleiotropic role of exchange protein directly activated by cAMP 1 (EPAC1) in cancer: implications for therapeutic intervention.Low β₂-adrenergic receptor level may promote development of castration resistant prostate cancer and altered steroid metabolism.Modeling prostate cancer in mice: limitations and opportunitiesAlternative Splicing Regulation of Cancer-Related Pathways in Caenorhabditis elegans: An In Vivo Model System with a Powerful Reverse Genetics ToolboxGRK3 is a direct target of CREB activation and regulates neuroendocrine differentiation of prostate cancer cells.'Reduced malignancy as a mechanism for longevity in mice with adenylyl cyclase type 5 disruption'.Role of gonadal hormones in programming developmental changes in thymopoietic efficiency and sexual diergism in thymopoiesis.Signal transduction pathways and transcriptional mechanisms of ABCB1/Pgp-mediated multiple drug resistance in human cancer cells.Dual blockade of PKA and NF-κB inhibits H2 relaxin-mediated castrate-resistant growth of prostate cancer sublines and induces apoptosis.Targeting protein kinase A in cancer therapy: an update.Transporter effects on cell permeability in drug delivery.Enhanced inhibition of prostate tumor growth by dual targeting the androgen receptor and the regulatory subunit type iα of protein kinase a in vivoHuman PDE4D isoform composition is deregulated in primary prostate cancer and indicative for disease progression and development of distant metastases.Downregulation of phosphodiesterase 4B (PDE4B) activates protein kinase A and contributes to the progression of prostate cancer.Cyr61 is regulated by cAMP-dependent protein kinase with serum levels correlating with prostate cancer aggressiveness.The activity of cAMP-phosphodiesterase 4D7 (PDE4D7) is regulated by protein kinase A-dependent phosphorylation within its unique N-terminus.Protein kinase a in cancerComparative kinome analysis to identify putative colon tumor biomarkers.Urology pertinent neuroendocrine tumors: focusing on renal pelvis, bladder, prostate located sympathetic functional paragangliomas.Use of β-blockers is associated with prostate cancer-specific survival in prostate cancer patients on androgen deprivation therapy.Microinsertions in PRKACA cause activation of the protein kinase A pathway in cardiac myxoma.Investigation of the molecular mechanisms underlying postoperative recurrence in prostate cancer by gene expression profiling.Androgen receptor signaling regulates T-type Ca2+ channel expression and neuroendocrine differentiation in prostate cancer cells.
P2860
Q24337313-63C5F171-A9D4-45AD-A66F-A4E4C73C4AACQ26771250-8DF74729-B747-490A-9CE8-0C4CE9EE1EE9Q26859201-B45A8898-81C3-407D-B6FB-03EB3893B164Q27011309-86F1C6F1-E3AC-40ED-9BE2-CFF7B51744C8Q28084943-DFA174F0-19B7-4958-ABE4-A7C595C3F58BQ28269917-C48E2DA9-F2AC-4D28-9297-4C49A6928E49Q28307581-A52F5BE2-8E7D-4B40-A0E9-FF6F12F8BCB9Q28482126-6C457BA4-C9AF-4E2F-8610-574C6B73CB30Q28567904-04674DBD-CD88-4471-8E29-A5CACCEB8D3DQ34144663-A3E89366-2041-4715-AC58-52DE5D5697F6Q34313140-BE73028D-5383-438B-B8BF-22B1CC5A4D32Q34318699-9C93E690-6114-42D4-8F36-A565C7CE5CE0Q35380936-E2A0AF14-ADE9-4C0D-8D37-3179129DE983Q35615320-5926843B-C004-42F7-81C0-534B5BA3ACFDQ35843428-7BFC75C7-452F-45F9-999B-13A2B8CA5F3BQ35874404-1FE80473-5F03-45DA-BD46-0B0F161FFDB7Q36139948-EDF50C37-7565-46C1-BEC2-F4C996397E37Q36398745-C62353DF-6C66-484F-B611-8F960FE14FD4Q36738996-19A9D82E-156D-4AD4-A961-7E5A3A87D972Q37053034-71C7575F-ECA9-472F-9BC6-12AF4313D994Q37166624-BA20A7EB-0344-4993-8B07-1A9961AB84ACQ37564369-25A58974-4C01-48AC-97A6-D45744B6A959Q37693261-4923FAFC-85EB-450E-AFAA-D16FD1BD022DQ37992541-4C0A9169-3ABF-4DF3-A332-F97E44ACF37FQ38011895-E0F9933E-4F61-4FFA-8B71-742AE2B6821CQ38501336-3D36D269-1100-4FDD-88F7-AF91B50677BEQ38594971-9408AF63-0824-475C-8F22-0251A05DC216Q38905979-41167640-68FA-4E08-AFB9-B0C45D572FAAQ39143940-3646886B-4F56-4613-89FD-F4578F5F5641Q39341456-0081CA41-94A0-4776-8803-3E8EB3302031Q39359743-0A22F4F8-9EE2-4A3A-B235-7006D1056C65Q39453245-4284FAC4-55E3-4607-9C8E-D37788D3FDCAQ41438364-D5FB8DAD-020F-414A-A1CC-08FD3999AD47Q41812476-48C9E7B4-51D9-4AC1-8633-73FB6608411EQ42250395-65E8D887-5212-45C0-9966-0B25B7A6EBE7Q42427772-6E15439B-41E0-4007-9C76-B15DEB497C08Q44279417-E1952538-D473-4562-9AB6-504A45D4759BQ48334823-4ACB8C62-5032-43F1-87CB-14D2ABD5A88DQ49335670-48D57F2D-5BC5-4066-9DAA-2BC66EF43B60Q53686355-F7237B34-EF1B-4EBF-9CB9-976025B2490A
P2860
Roles of cAMP and cAMP-dependent protein kinase in the progression of prostate cancer: cross-talk with the androgen receptor.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 08 September 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Roles of cAMP and cAMP-depende ...... lk with the androgen receptor.
@en
Roles of cAMP and cAMP-depende ...... lk with the androgen receptor.
@nl
type
label
Roles of cAMP and cAMP-depende ...... lk with the androgen receptor.
@en
Roles of cAMP and cAMP-depende ...... lk with the androgen receptor.
@nl
prefLabel
Roles of cAMP and cAMP-depende ...... lk with the androgen receptor.
@en
Roles of cAMP and cAMP-depende ...... lk with the androgen receptor.
@nl
P1433
P1476
Roles of cAMP and cAMP-depende ...... lk with the androgen receptor.
@en
P2093
Dennis Merkle
Ralf Hoffmann
P304
P356
10.1016/J.CELLSIG.2010.08.017
P577
2010-09-08T00:00:00Z